Kala Pharmaceuticals Financials
| KALA Stock | USD 6.92 0.12 1.76% |
Kala |
Please note, the presentation of Kala Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kala Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kala Pharmaceuticals' management manipulating its earnings.
Kala Pharmaceuticals Stock Summary
Kala Pharmaceuticals competes with Lifecore Biomedical, Shuttle Pharmaceuticals, Journey Medical, Akanda Corp, and Organogenesis Holdings. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts. Kala Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US4831192020 |
| CUSIP | 483119103 483119202 |
| Location | Massachusetts; U.S.A |
| Business Address | 1167 Massachusetts Avenue, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.kalarx.com |
| Phone | 781 996 5252 |
| Currency | USD - US Dollar |
Kala Pharmaceuticals Key Financial Ratios
Kala Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kala Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Kala Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kala Pharmaceuticals competition to find correlations between indicators driving Kala Pharmaceuticals's intrinsic value. More Info.Kala Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kala Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Kala Pharmaceuticals Systematic Risk
Kala Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kala Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Kala Pharmaceuticals correlated with the market. If Beta is less than 0 Kala Pharmaceuticals generally moves in the opposite direction as compared to the market. If Kala Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kala Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kala Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Kala Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Kala Pharmaceuticals Financials
What exactly are Kala Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Kala Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Kala Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Kala Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Kala Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kala Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Kala Pharmaceuticals March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kala Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kala Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kala Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Kala Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kala Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.38 | |||
| Information Ratio | 0.0806 | |||
| Maximum Drawdown | 42.84 | |||
| Value At Risk | (6.53) | |||
| Potential Upside | 9.39 |
Complementary Tools for Kala Stock analysis
When running Kala Pharmaceuticals' price analysis, check to measure Kala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kala Pharmaceuticals is operating at the current time. Most of Kala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |